<DOC>
	<DOCNO>NCT01227954</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high energy x-ray kill tumor cell . PURPOSE : This phase II trial study well avoid hippocampus whole-brain radiation therapy work treat patient brain metastasis .</brief_summary>
	<brief_title>Avoiding Hippocampus During Whole-Brain Radiation Therapy Treating Patients With Brain Metastases</brief_title>
	<detailed_description>OBJECTIVES : Primary - Evaluate delay recall assess Hopkins Verbal Learning Test-Revised ( HVTL-R ) 4 month hippocampal avoidance whole-brain radiotherapy ( HA-WBRT ) patient brain metastasis . Secondary - Evaluate auditory visual learning memory , assess 2 CogState test ( International Shopping List Test One Card Learning Test ) , HA-WBRT patient . - Compare psychometric property 2 CogState test HVLT-R assessment memory decline HA-WBRT patient . - Evaluate health-related quality life [ assess Functional Assessment Cancer Therapy Brain Subscale ( FACT-BR ) Barthel Index Activities Daily Living ( ADLs ) ] HA-WBRT patient . - Evaluate time radiographic progression HA-WBRT patient . - Evaluate overall survival patient HA-WBR . - Evaluate adverse event HA-WBR . - Evaluate predictive biomarkers cognitive function . OUTLINE : This multicenter study . Patients undergo 10 fraction intensity-modulated whole-brain radiotherapy ( WBRT ) , avoid hippocampal ( HA ) region , daily , 5 day week , 2-2½ week . Patients neurocognitive function ( delay recall , auditory visual learning , memory ) evaluate Hopkins Verbal Learning Test-Revised ( HVTL-R ) , The One Card Learning Test ( OCLT ) , International Shopping List Test ( ISLT ) baseline periodically study . Patients may undergo serum , plasma , whole blood collection baseline 4 month completion HA-WBRT correlative study . Patients may complete Functional Assessment Cancer Therapy Brain Subscale ( FACT-BR ) , Barthel Index Activities Daily Living ( ADLs ) quality-of-life questionnaire baseline periodically study follow . After completion study therapy , patient follow periodically .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>INCLUSION CRITERIA : Histologically cytologically confirm nonhematopoietic malignancy within past 5 year If histologic proof malignancy &gt; 5 year ago , recent pathological confirmation require ( e.g. , systemic metastatic brain metastasis ) Patients metastasis unknown primary tumor permit Measurable brain metastasis outside 5mm margin around either hippocampus gadolinium contrastenhanced MRI obtain within past 30 day Have treat stereotactic radiosurgery ( SRS ) surgical resection These treatment option allow relapse Patients brain metastases initial presentation allow need demonstrate 3 month stable scan At least 1 week since open biopsy Karnofsky performance status 70100 % Fertile patient must use effective contraception Negative pregnancy test 2 week less prior study entry Patients must English proficient , patient speak English second language eligible EXCLUSION CRITERIA : Small cell lung cancer germ cell malignancy Leptomeningeal metastases Nonsmall cell lung cancerassociated brain metastasis ≥ 2 organ site extracranial metastasis Radiologic evidence hydrocephalus Serum creatinine &gt; 1.4 mg/dL within 30 day prior study entry Pregnant nursing Contraindication MR image implant metal device foreign body severe claustrophobia Severe , active comorbidity include follow : Unstable angina and/or congestive heart failure require hospitalization within past 6 month Transmural myocardial infarction within past 6 month Acute bacterial fungal infection require intravenous antibiotic Hepatic insufficiency result clinical jaundice and/or coagulation defect Chronic obstructive pulmonary disease exacerbation respiratory illness require hospitalization preclude study therapy Uncontrolled , clinically significant cardiac arrhythmia Prior radiotherapy brain Plan chemotherapy targeted therapy WBRT subsequent 7 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>cognitive/functional effect</keyword>
	<keyword>tumor metastatic brain</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>